| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 15.62B | 6.46B | 7.30B | 8.26B | 6.02B |
| Gross Profit | 10.37B | 6.46B | 4.04B | 3.63B | 4.61B |
| EBITDA | 6.32B | 2.35B | 1.06B | 1.15B | 4.82B |
| Net Income | 2.22B | -776.70M | -125.40M | -1.22B | 6.69B |
Balance Sheet | |||||
| Total Assets | 112.86B | 113.96B | 113.82B | 113.25B | 120.31B |
| Cash, Cash Equivalents and Short-Term Investments | 17.57B | 15.14B | 14.70B | 20.36B | 10.90B |
| Total Debt | 18.14B | 8.68B | 24.76B | 24.55B | 29.50B |
| Total Liabilities | 43.01B | 48.19B | 46.42B | 45.04B | 46.46B |
| Stockholders Equity | 45.44B | 42.52B | 43.54B | 43.11B | 46.21B |
Cash Flow | |||||
| Free Cash Flow | 2.05B | 6.79B | 1.03B | 12.28B | -1.11B |
| Operating Cash Flow | 2.37B | 7.04B | 1.24B | 12.39B | -1.00B |
| Investing Cash Flow | -3.51B | -1.19B | 3.38B | -4.51B | 2.55B |
| Financing Cash Flow | -3.01B | -5.19B | -1.11B | -5.99B | 490.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$3.61B | 6.98 | 10.64% | 6.92% | 2.87% | 16.91% | |
70 Outperform | HK$8.18B | 4.92 | 5.71% | 6.47% | 27.07% | 322.17% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | HK$19.85B | 3.99 | 11.65% | 5.84% | -2.83% | 11.78% | |
60 Neutral | HK$9.31B | 9.07 | 11.99% | 3.17% | 14.18% | 20.76% | |
58 Neutral | HK$8.33B | 3.65 | 4.94% | ― | 108.24% | ― | |
54 Neutral | HK$34.50B | 8.66 | 7.55% | 6.69% | -5.86% | -4.69% |